2021 National Adult and Influenza Immunization Summit Virtual Meeting

Developing COVID-19 Vaccines in Record Time, Part 3: Update on Vaccines

January 29, 2021

At this follow-up to two virtual meetings on COVID-19 vaccines conducted by the National Adult and Influenza Immunization Summit (NAIIS) in 2020, 8 vaccine manufacturers presented information on their COVID-19 vaccines and/or vaccine candidates in later clinical trial phases (Phase 2/3), as well as vaccines in earlier phases of clinical development. Information presented included (1) published or other data plus timing of next trial phases; (2) published Phase 2 data as well as a description and update on progress of Phase 3 trials; or (3) current vaccines and their roll out. Presenters also discussed the availability of doses over the next few months and provided an update on any other studies underway or planned. After the presentations, a moderated discussion was held including topics such as understanding SARS-CoV2 variants/mutations and their impact on vaccines, manufacturer thoughts about the duration of immunity and interruption of transmission, and answers to questions from attendees.

During this virtual meeting, the panel members provided updates on COVID-19 vaccine development. Please check below to access individual presentations shared during the meeting.


  • Introduction (slides)
    Phyllis Arthur, MBA
    Vice President, Infectious Diseases & Diagnostics Policy
  • Pfizer
    Phil Dormitzer MD, PhD
    Vice President and Chief Strategy Officer, Viral Vaccines
    (presentation not posted per presenter’s request)
  • Moderna (slides)
    Patricia Novy, PhD
    Senior Director, Medical Affairs
    Video: Moderna COVID-19 Vaccine mRNA-1273
  • Janssen
    Rick Nettles, MD
    Vice President, Medical Affairs
    (presentation not posted per presenter’s request)
  • AstraZeneca (slides)
    Lisa Glasser, MD
    US Medical Affairs, Head, Vaccines-Infectious Disease
    Video: AztraZeneca COVID-19 Vaccine AZD1222
  • Novavax (slides)
    Greg Glenn, MD
    President, Research and Development
    Video: Creating Tomorrow’s Vaccines Today
  • Medicago
    Brian Ward, MD
    Medical Officer
    (presentation not posted per presenter’s request)
  • Sanofi (slides)
    Michael Greenburg, MD, MPH
    Medical Head, North America
    Video: Fighting COVID-19
  • Inovio (slides)
    Mammen ‘Anza’ Mammen, MD
    Senior Vice President, Clinical Development

    Jean Boyer, PhD
    Vice President, Research and Development
    Video: INO-4800 Non-Confidential Presentation